Aprio Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Aprio Wealth Management's VRTX Position: Q2 2026 in Review
Aprio Wealth Management reduced its Vertex Pharmaceuticals (VRTX) stake by 2.8% in Q2 2026, selling an estimated $7.53K and leaving 600 shares worth $298K. The position accounts for 0.01% of the portfolio, ranked #511.
Aprio Wealth Management first reported a position in VRTX in Q2 2025 and has held it in 4 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Aprio Wealth Management held 600 shares of Vertex Pharmaceuticals worth $298K as of Q2 2026.
- Aprio Wealth Management sold 17 Vertex Pharmaceuticals shares in Q2 2026, an estimated $7.53K.
- Vertex Pharmaceuticals made up 0.01% of Aprio Wealth Management's portfolio in Q2 2026, its #511 holding.
- Aprio Wealth Management first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Aprio Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.